Thus, the overexpression of ERK1/2 and MITF, observed in most of the tested samples, may play some positive roles; however, the effect requires further research and should be considered regarding the use of tetracyclines as adjuvant therapy for melanoma. This evidence concerns the gene MITF and melanoma.